Cytotoxic components from the dried rhizomes of Zingiber officinale Roscoe

Archives of Pharmacal Research

Volumn 31, Issue 4, 2008, Pages 415-418

  Kim, Ju Sin ^a   Lee, Sa Im ^a   Park, Hye Won ^a   Yang, Jae Heon ^a   Shin, Tae Yong ^a   Kim, Youn Chul ^b   Baek, Nam In ^c   Kim, Sung Hoon ^c   Choi, Sang Un ^d   Kwon, Byoung Mog ^e   Leem, Kang Hyun ^f   Jung, Mun Yhung ^a   Kim, Dae Keun ^a  

^a Woosuk University   (South Korea)

^b Wonkwang University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Korea Research Institute of Chemical Technology   (South Korea)

^e Korea Institute of Science and Technology   (South Korea)

^f Semyung University   (South Korea)

Author keywords

Cell proliferation; Cytotoxicity; Gingerol; Shogaol; Zingiber officinale; Zingiberaceae

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHOL DERIVATIVE; FATTY ALCOHOL; GINGEROL; SHOGAOL;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DESICCATION; DOSE RESPONSE; DRUG EFFECT; GINGER; HUMAN; IC 50; ISOLATION AND PURIFICATION; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RHIZOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATECHOLS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DESICCATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ALCOHOLS; GINGER; HUMANS; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR STRUCTURE; RHIZOME;

EID: 43049142617     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1172-y     Document Type: Article

References (15)

1. But, P. P. H., Kimura, T., Guo, J.-X., and Sung, C. K., International collation of traditional and folk medicine. World Scientific, Singapore, p. 400, (1997).
2. Denniff, P., Macleod, I., and Whiting, A. A., Studies in the biosynthesis of [6]-gingerol, pungent principle of ginger (Zingiber officinale). J. C. S. Perkin I, 2637-2644 (1980).
3. Hori, Y., Miura, T., Hirai, Y., Fukumura, M., Nemoto, Y., Toriizuka, K., and Ida, Y., Pharmacognostic studies on ginger and related drugs-part 1: five sulfonated compounds from Zingiberis rhizome (Shokyo). Phytochemistry 62, 613-617 (2003).
4. Jang, I. M., Treatise on Asian herbal medicines. Daewon, Seoul, pp. 1030-1031, (2003).
5. 2 production. Phytochemistry 66, 1614-1635 (2005).
6. Lee, E. and Surh, Y.-J., Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-6gingerol and [6]-paradol. Cancer Lett. 134, 163-168 (1998).
7. Ma, J., Jin, X., Yang, L., and Liu, Z.-L., Diarylheptanoids from the rhizomes of Zingiber officianle. Phytochemistry 65, 1137-1143 (2004).
8. Masuda, Y., Kikuzaki, H., Hisamoto, M., and Nakatani, N., Antioxidant properties of gingerol related compounds from ginger. BioFactors 21, 293-296 (2004).
9. Miyoshi, N., Nakamura, Y., Ueda, Y., Abe, M., Ozawa, Y., Uchida, K., and Osawa, T., Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in Human T lymphoma Jurkat cells. Cancer Lett. 199, 113-119 (2003).
10. Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., and Varmus, H. E., Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell. 1, 53-62 (2002).
11. Ryu, S. Y., Choi, S. U., Lee, C. O., and Zee, O. P., Antitumor activity of Psoralea corylifolia. Arch. Pharm. Res., 15, 356-359 (1992).
12. Shoji, N., Iwasa, A., Takemoto, T., Ishida, Y., and Ohizumi, Y., Cardiotonic principles of ginger (Zingiber officinale Roscoe). J. Pharm. Sci. 71, 1174-1175 (1982).
13. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).
14. Wei, Q.-Y., Ma, J.-P., Cai, Y.-J., Yang, L., and Liu, Z.-L., Cytotoxic and apoptotic activities of diarylheptanoids and gingerol-related compounds from the rhizome of Chinese ginger. J. Ethnopharmacol., 102, 177-184 (2005).
15. Xing, D. and Orsulic, S., A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. P. N. A. S., 102, 6936-6941 (2005).